Abiopharma

🔍 Karp Jason H. (Director)

Company: Grove Collaborative Holdings, Inc. (GROV)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 55,000 shares of Class A Common Stock at $1.0278 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 575,000.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 15,200 shares of Class A Common Stock at $1.0761 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 590,200.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: by LLC | shares_owned_after: 1,111,110.00 | Footnotes: F3

Footnotes:

• F1: The transaction was executed in multiple trades in prices ranging from $.99 to $1.0873, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote of this Form 4.
• F2: The transaction was executed in multiple trades in prices ranging from $1.04 to $1.0799, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote of this Form 4.
• F3: These securities are directly held by HCI Grove, LLC. of which the Reporting Person is the sole Manager.